COMPUGEN LTD
AI-driven discovery of novel cancer immunotherapies for treatment-resistant patients.
CGEN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 26 HAROKMIM STREET, 5885849 HOLON
- Website:
- https://cgen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Compugen Ltd. is a clinical-stage cancer immunotherapy company that specializes in the discovery and development of novel therapeutics. The company leverages its proprietary AI and machine learning-powered computational discovery platform, Unigen™, to identify and validate novel drug targets and create first-in-class treatments. Compugen's primary focus is developing new therapeutic options for cancer patients who are refractory or unresponsive to existing drugs. Its pipeline includes therapeutic antibodies targeting novel immune checkpoint pathways, such as the PVRIG pathway it discovered, which are being evaluated in multiple clinical trials. By integrating predictive computational biology with deep scientific expertise, Compugen aims to expand the landscape of cancer immunotherapy through both monotherapy and combination approaches.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all COMPUGEN LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for COMPUGEN LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for COMPUGEN LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
